France· FR:63755329
ANTARENE CODEINE 200 mg/30 mg, comprimé pelliculé
A medicinal product containing ibuprofène + phosphate de codéine hémihydraté, registered in France by ELERTE, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- IBUPROFÈNE + PHOSPHATE DE CODÉINE HÉMIHYDRATÉ
- Manufacturer
- ELERTE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400939755588plaquette(s) thermoformée(s) PVC-Aluminium de 20 comprimé(s)EUR 2.01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ibuprofène + phosphate de codéine hémihydraté in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBoots Ibuprofen and Codeine 200mg/12.8mg tabletsThe Boots Company Plc
- SpainASTEFOR 400/30 mg COMPRIMIDOS RECUBIERTOS CON PELICULAFarmasierra Laboratorios S.L.
- FinlandArdinexViatris Oy
- IrelandNurofen Plus Tablets Ibuprofen 200 mg Codeine Phosphate Hemihydrate 12.8 mgPCO Manufacturing Ltd.
- PolandNurofen PlusReckitt Benckiser (Poland) S.A.
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Belgium · Brufen
- Estonia · Brufen Plus
- Spain · Astefor, Neobrufen
- Finland · Ardinex
- United Kingdom (Northern Ireland) · Ibuprofen And Codeine The Boots Company, Nurofen
- Greece · Brufen Plus
- Ireland · Nurofen Plus
- Italy · Brufecod
- Luxembourg · Brufen
- Latvia · Brufen Plus
- Malta · Nurofen Plus
- Poland · Nurofen Plus
- Romania · Biofen Plus, Brufen Plus
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d5f51744-63c9-4d85-bcd0-f5dd25ed4d48 GET /v1/drugs/d5f51744-63c9-4d85-bcd0-f5dd25ed4d48?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "63755329",
"date_amm": "2009-10-05",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "IBUPROFÈNE + PHOSPHATE DE CODÉINE HÉMIHYDRATÉ",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about ibuprofène + phosphate de codéine hémihydraté.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.